ClassID:

20248

A61K31/203 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids Retinoic acids Salts thereof

Recent Application in this class:
#301
20180064777
2018-03-08

Skin Solution with Solubilized Bakuchiol

#302
20180064666
2018-03-08

Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions

#303
20180050048
2018-02-22

CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF

#304
20180028438
2018-02-01

Topical formulation

#305
20180008644
2018-01-11

WOUND HEALING

#306
20170369503
2017-12-28

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

#307
20170354597
2017-12-14

NONSTEROIDAL IMMUNOMODULATING KIT AND COMPOSITION AND USES THEREOF

#308
20170349628
2017-12-07

Synthesis of cell penetrating peptides for drug delivery and stem cell applications

#309
20170340677
2017-11-30

Method for producing therapeutic corneal endothelial substitute cell sphere

#310
20170340625
2017-11-30

Composition and method for treating skin conditions

#311
20170340603
2017-11-30

Compositions and methods for skin care

#312
20170340594
2017-11-30

Pharmaceutical compositions for treating acne

#313
20170326159
2017-11-16

METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID

#314
20170326092
2017-11-16

ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

#315
20170326091
2017-11-16

LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

#316
20170319531
2017-11-09

Composition and method for treating neuronal ceroid lipofuscinosis

#317
20170296567
2017-10-19

Decubitus Ulcer Salve

#318
20170290915
2017-10-12

METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMOR

#319
20170281566
2017-10-05

COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

#320
20170281563
2017-10-05

Method of reducing scarring

#321
20170274009
2017-09-28

Compositions and methods to affect skin irritation

#322
20170273988
2017-09-28

Methods of treating lymphoma using thienotriazolodiazepine compounds

#323
20170258748
2017-09-14

ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

#324
20170231919
2017-08-17

DELIVERY SYSTEMS

#325
20170218068
2017-08-03

Method for the identification of immunotherapy-drug combinations using a network approach

#326
20170209403
2017-07-27

METHOD FOR REGULATING ALDEHYDE DEHYDROGENASE 1

#327
20170209371
2017-07-27

Phosphoserine containing compositions for immune tolerance induction

#328
20170204466
2017-07-20

Biomarkers for Pin1-associated disorders

#329
20170202799
2017-07-20

ATRA for modulating Pin1 activity and stability

#330
20170182075
2017-06-29

Anti-aging compositions and methods for using same

#331
20170182071
2017-06-29

Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition

#332
20170165218
2017-06-15

Low dose oral pharmaceutical composition of isotretinoin

#333
20170165217
2017-06-15

LIQUID DOSAGE FORMS OF ISOTRETINOIN

#334
20170145382
2017-05-25

Method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients

#335
20170143832
2017-05-25

Semifluorinated alkane compositions

#336
20170128403
2017-05-11

COMPOSITIONS AND METHODS FOR TREATING MACULAR DEGENERATION

#337
20170112792
2017-04-27

ENHANCED ATRA-RELATED COMPOUNDS DERIVED FROM STRUCTURE-ACTIVITY RELATIONSHIPS AND MODELING FOR INHIBITING PIN1

#338
20170107295
2017-04-20

Combination therapies with anti-CD38 antibodies

#339
20170100358
2017-04-13

Use of retinoic acid and analogs thereof to treat central neural apneas

#340
20170072010
2017-03-16

Combination therapy for head and neck cancer

#341
20170049795
2017-02-23

Composition and methods of treating acne and photoaging

#342
20170049789
2017-02-23

Topical film delivery system

#343
20170049732
2017-02-23

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

#344
20170049712
2017-02-23

Topical film delivery system

#345
20170035847
2017-02-09

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION-ASSOCIATED DISORDERS OF THE GASTROINTESTINAL TRACT

#346
20170007539
2017-01-12

Pharmaceutical compositions comprising silica microspheres

#347
20160367528
2016-12-22

Composition comprising a diindolylmethane and a retinoid to treat a skin condition

#348
20160367488
2016-12-22

FORMULATION FOR RETINOID-CONTAINING SOFT GELATIN CAPSULES

#349
20160361470
2016-12-15

Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto

#350
20160361282
2016-12-15

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

#351
20160346241
2016-12-01

ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

#352
20160338985
2016-11-24

Topical solution of isotretinoin

#353
20160338984
2016-11-24

Particle formulations of all-trans retinoic acid and transforming growth factor beta for the treatment of type 1 diabetes mellitus

#354
20160317654
2016-11-03

COMBINATION THERAPY WITH RAR ALPHA AGONISTS FOR ENHANCING TH1 RESPONSE

#355
20160317579
2016-11-03

Combination of an arsenic compound and at least one retinoid for treating acute myeloid leukemia

#356
20160310439
2016-10-27

Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use of same in dermatology

#357
20160310400
2016-10-27

METHOD FOR PREPARING LIPOSOMES OF RETINALDEHYDE OR OTHER PRECURSORS OF RETINOIC ACID AND PRODUCT THUS OBTAINED

#358
20160304970
2016-10-20

GENE BIOMARKER TO DIAGNOSE METASTIC LIVER CANCER AND METHODS FOR TARGETING THE SAME

#359
20160303005
2016-10-20

Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics

#360
20160263212
2016-09-15

COMPOSITIONS AND METHODS FOR TOLERIZING THE IMMUNE SYSTEM TO ALLERGENS

#361
20160256675
2016-09-08

Methods and systems for material transport across an impermeable or semi-permeable membrane via artificially created microchannels

#362
20160244720
2016-08-25

Medium for preparing a neural cell and usage thereof

#363
20160235862
2016-08-18

Vaults engineered for hydrophobic drug delivery

#364
20160235770
2016-08-18

METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID

#365
20160220673
2016-08-04

Light-activatable polymeric nanoparticles

#366
20160206624
2016-07-21

Medicament for treatment of Alzheimer's disease

#367
20160184354
2016-06-30

ROSACEA TREATMENTS AND KITS FOR PERFORMING THEM

#368
20160143941
2016-05-26

NUTRACEUTICAL COMPOSITION AND METHODS FOR PREVENTING OR TREATING MULTIPLE SCLEROSIS

#369
20160120986
2016-05-05

Delivery systems

#370
20160120803
2016-05-05

NON-AEROSOL FOAMS FOR TOPICAL ADMINISTRATION

#371
20160089353
2016-03-31

Oral pharmaceutical composition of isotretinoin

#372
20160081965
2016-03-24

ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN

#373
20160081964
2016-03-24

Oral pharmaceutical composition of isotretinoin

#374
20160074346
2016-03-17

Method of viral inhibition

#375
20160067205
2016-03-10

Combination Therapies with Anti-CD38 Antibodies

#376
20160051558
2016-02-25

Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells

#377
20160045499
2016-02-18

Minoxidil for suppressing androgen receptor function

#378
20160038490
2016-02-11

COMPOSITIONS AND METHODS FOR TREATING DYSPROLIFERATIVE DISEASES

#379
20160038478
2016-02-11

Composition and methods for treating skin conditions

#380
20160015909
2016-01-21

SYSTEM, RETAINER AND METHOD OF PROVIDING THERAPEUTIC TREATMENT FOR ACNE

#381
20160015494
2016-01-21

Dental and medical devices with light source and antimicrobial solution

#382
20150352070
2015-12-10

Methods of treating diseases associated with high-fat diet and vitamin A deficiency using retinoic acid receptor agonists

#383
20150335738
2015-11-26

SECRETORY IMMUNOGLOBULIN DEFICIENCY TREATMENT AND PROPHLAXIS

#384
20150320816
2015-11-12

COMPOSITIONS FOR PROMOTION OF WOUND HEALING AND/OR SCAR REDUCTION

#385
20150313863
2015-11-05

Composition and method for treating neuronal ceroid lipofuscinosis

#386
20150306070
2015-10-29

Use of maleimide derivatives for preventing and treating leukemia

#387
20150297555
2015-10-22

Combination therapeutics and methods for the treatment of neurodegenerative and other diseases

#388
20150290333
2015-10-15

PROCESS AND MATERIALS FOR MEDICAL APPLICATIONS

#389
20150290163
2015-10-15

RETINOIC ACID MICRONEEDLE

#390
20150265564
2015-09-24

Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis

#391
20150265539
2015-09-24

Formulation for retinoid-containing soft gelatin capsules

#392
20150250887
2015-09-10

METHOD OF PREPARING RESIN TINCTURES

#393
20150238605
2015-08-27

Semifluorinated alkane compositions

#394
20150209342
2015-07-30

TOPICAL RETINOID FORMULATIONS, PROCESSES FOR MAKING AND METHODS OF USE

#395
20150202172
2015-07-23

NOVEL METHOD OF USE

#396
20150164907
2015-06-18

COMPOSITIONS AND METHODS FOR TREATING DISEASE

#397
20150150822
2015-06-04

NOVEL CORE-SHELL NANOPARTICLES FOR ORAL DRUG DELIVERY

#398
20150125520
2015-05-07

Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing the same, process for preparing the same and use thereof in dermatology

#399
20150098918
2015-04-09

Cream gels comprising at least one retinoid and benzoyl peroxide

#400
20150093445
2015-04-02

Formulations and methods for treatment of acne and inflammatory skin conditions

#401
20150086644
2015-03-26

Formulations and methods for treatment of inflammatory skin diseases

#402
20150080353
2015-03-19

Pharmaceutical compositions for the delivery of substantially water-insoluble drugs

#403
20150079182
2015-03-19

Pharmaceutical compositions comprising silica microspheres

#404
20150079155
2015-03-19

Cationic Liposomal Drug Delivery System for Specific Targeting of Human CD14+ Monocytes in Whole Blood

#405
20150079026
2015-03-19

Controlled release formulations for the induction and proliferation of blood cells

#406
20150072996
2015-03-12

Formulations and methods for treatment of wounds and inflammatory skin conditions

#407
20150071880
2015-03-12

TREATMENT OF EPITHELIAL LAYER LESIONS

#408
20150045440
2015-02-12

Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid

#409
20150044278
2015-02-12

Methods and compositions for the treatment of proliferative disorders

#410
20150031610
2015-01-29

DERIVATIZED POLYGLUCOSAMINES FOR DELIVERY OF SMALL MOLECULES, PEPTIDES, AND PROTEINS

#411
20140364400
2014-12-11

Esters for treatment of ocular inflammatory conditions

#412
20140350106
2014-11-27

Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same

#413
20140348938
2014-11-27

Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins

#414
20140323507
2014-10-30

Mycophenolic acid analogues as anti-tumor chemosensitizing agents

#415
20140315990
2014-10-23

PKC activators and combinations thereof

#416
20140308223
2014-10-16

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

#417
20140303251
2014-10-09

Methods Of Treating Acute Kidney Injury With Retinoic Acid

#418
20140271875
2014-09-18

Compositions including encapsulated isotretinoin and methods for use thereof

#419
20140249232
2014-09-04

Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

#420
20140249118
2014-09-04

TREATMENT OF ORAL LICHEN PLANUS WITH A COMBINATION OF TRIAMCINOLONE AND RETINOIC ACID

#421
20140248220
2014-09-04

Foamable suspension gel

#422
20140234452
2014-08-21

Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer

#423
20140219957
2014-08-07

Methods for the treatment of immune disorders

#424
20140205661
2014-07-24

Formulation for retinoid-containing soft gelatin capsules

#425
20140187504
2014-07-03

Prevention and treatment of inflammatory conditions

#426
20140171399
2014-06-19

Topical skin care composition

#427
20140170201
2014-06-19

Uniform field magnetization and targeting of therapeutic formulations

#428
20140163102
2014-06-12

MEDICAL DRESSING FOR RESPIRATORY EPITHELIAL CELLS

#429
20140147504
2014-05-29

Tetracycline topical formulations, preparation and uses thereof

#430
20140142072
2014-05-22

Composition comprising a diindolylmethane and a retinoid to treat a skin condition

#431
20140134112
2014-05-15

Topical pharmaceutical foam composition

#432
20140107203
2014-04-17

Pharmaceutical semi-solid composition of isotretinoin

#433
20140105967
2014-04-17

STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT

#434
20140086909
2014-03-27

Methods and compositions for the treatment of proliferative disorders

#435
20140080775
2014-03-20

MOLECULAR MODULATORS OF THE WNT/BETA-CATENIN PATHWAY

#436
20140066414
2014-03-06

Topical compositions for treatment of skin conditions

#437
20140057982
2014-02-27

RETINOIDS AND USE THEREOF

#438
20140037771
2014-02-06

Composition comprising Retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer

#439
20140037700
2014-02-06

Composition and Method for Enhancing an Immune Response

#440
20140018437
2014-01-16

Treatment of inflammatory and infectious skin disorders

#441
20140018332
2014-01-16

Methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analog with or without a retinoid

#442
20140010902
2014-01-09

EXCIPIENT SYSTEM FOR TOPICAL DELIVERY OF PHARMACEUTICAL AGENTS

#443
20140004082
2014-01-02

Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

#444
20130337077
2013-12-19

Nanospheres for therapeutic agent delivery

#445
20130317096
2013-11-28

SYNERGISTIC INTERACTION OF AT LEAST ONE VITAMIN E COMPONENT AND TYROSINASE INHIBITORS FOR DERMATOLOGICAL APPLICATIONS

#446
20130315962
2013-11-28

METHOD FOR STEM CELL DIFFERENTIATION IN VIVO BY DELIVERY OF MORPHOGENES WITH MESOPOROUS SILICA AND CORRESPONDING PHARMCEUTICAL ACTIVE INGREDIENTS

#447
20130302402
2013-11-14

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

#448
20130280309
2013-10-24

Foamable suspension gel

#449
20130273019
2013-10-17

Compositions for topical treatment of medical conditions including wounds and inflammation

#450
20130267598
2013-10-10

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME

#451
20130267486
2013-10-10

Polymeric topical compositions

#452
20130237505
2013-09-12

Topical compositions for treatment of skin conditions

#453
20130217769
2013-08-22

Pharmaceutical semi-solid composition of isotretinoin

#454
20130202712
2013-08-08

Compositions And Methods For Treating Or Preventing Immuno-Inflammatory Disease

#455
20130158119
2013-06-20

Pharmaceutical semi-solid composition of isotretinoin

#456
20130156865
2013-06-20

POTENTIATION INDUCED BY PDE4 INHIBITORS IN THE TREATMENT OF LEUKEMIA

#457
20130143950
2013-06-06

Compounds and Methods for the Treatment of Cancer

#458
20130123363
2013-05-16

Medicinal agent for prevention and/or treatment of hepatocellular carcinoma

#459
20130123327
2013-05-16

Combined use of PRAME inhibitors and HDAC inhibitors

#460
20130096361
2013-04-18

Uniform field magnetization and targeting of therapeutic formulations

#461
20130095185
2013-04-18

Stabilized topical formulations containing core-shell microcapsules

#462
20130072555
2013-03-21

Methods for treating obesity or an obesity related condition

#463
20130039995
2013-02-14

DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE REINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE

#464
20130039869
2013-02-14

Rosacea treatments and kits for performing them

#465
20130023487
2013-01-24

Compounds and compositions for treating infection

#466
20130012475
2013-01-10

Cosmetic and pharmaceutical composition comprising N-acetylglucosamine-6-phosphate

#467
20130011452
2013-01-10

Topical foam composition

#468
20130011370
2013-01-10

Uniform Field Magnetization and Targeting of Therapeutic Formulations

#469
20130005805
2013-01-03

Esters for treatment of ocular inflammatory conditions

#470
20130005774
2013-01-03

Topical foam composition

#471
20130005691
2013-01-03

Esters for treatment of ocular inflammatory conditions

#472
20120309087
2012-12-06

CANCER THERAPY

#473
20120288568
2012-11-15

METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION

#474
20120282314
2012-11-08

DERMATOLOGICAL/COSMETIC SKIN DEPIGMENTING COMPOSITIONS

#475
20120270837
2012-10-25

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#476
20120270736
2012-10-25

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

#477
20120269874
2012-10-25

Compositions for topical application comprising a peroxide and retinoid

#478
20120263666
2012-10-18

Topical skin care composition

#479
20120259014
2012-10-11

Topical retinoid solutions

#480
20120259013
2012-10-11

LIQUID DOSAGE FORMS OF ISOTRETINOIN

#481
20120252888
2012-10-04

Compositions and Methods for Treating Neurologic Disorders

#482
20120238632
2012-09-20

MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION

#483
20120231062
2012-09-13

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

#484
20120225911
2012-09-06

Replenishing body stores of fat-soluble vitamins A, and D eradicate chronic viral infection

#485
20120214870
2012-08-23

METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC FATIGUE SYNDROME

#486
20120189678
2012-07-26

Liposome and personal care composition comprising thereof

#487
20120157499
2012-06-21

DELIVERY OF AN ACTIVE DRUG TO THE POSTERIOR PART OF THE EYE VIA SUBCONJUNCTIVAL OR PERIOCULAR DELIVERY OF A PRODRUG

#488
20120149773
2012-06-14

Composition for skin improvement comprising hexamidines and retinoids

#489
20120148649
2012-06-14

COMPOSITION FOR RESTORATION OF AGE RELATED TISSUE IN THE FACE OR SELECTED AREAS OF THE BODY

#490
20120141576
2012-06-07

Treatment of Dermatologic Skin Disorders

#491
20120128598
2012-05-24

Topical Pharmaceutical Foam Composition

#492
20120121691
2012-05-17

Method for Increasing the Production of a Specific ACYL-Chain Dihydroceramide(s) for Improving the Effectiveness of Cancer Treatments

#493
20120121567
2012-05-17

Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique

#494
20120115954
2012-05-10

Aqueous retinoid and benzoyl peroxide gel

#495
20120115821
2012-05-10

COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS

#496
20120108658
2012-05-03

Ophthalmic composition

#497
20120108527
2012-05-03

Polymeric topical compositions

#498
20120100608
2012-04-26

LYMPHOCREME

#499
20120095097
2012-04-19

Ophthalmic composition

#500
20120089076
2012-04-12

Methods of treatment using anti-IL-20 antibodies

#501
20120077786
2012-03-29

METHODS AND COMPOSITIONS FOR DISEASE TREATMENT USING INHALATION

#502
20120064135
2012-03-15

Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof

#503
20120046354
2012-02-23

ANTI-OXIDANT LOZENGES FOR THE PREVENTION AND TREATMENT OF RADIATION INDUCED MUCOSITIS, PRECANCEROUS LESIONS, ORAL CANCER AND OTHER ORAL CAVITY MUCOSAL DISORDERS

#504
20120027675
2012-02-02

TARGETING PULMONARY EPITHELIUM USING ADRP

#505
20120009243
2012-01-12

LIPOSOMES FOR DRUG DELIVERY AND METHODS FOR PREPARATION THEREOF

#506
20110319491
2011-12-29

ANHYDROUS DEPIGMENTING COMPOSITIONS COMPRISING, WITHIN THE FATTY PHASE THEREOF, A SOLUBILIZED PHENOLIC COMPOUND AND A RETINOID

#507
20110318396
2011-12-29

Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide

#508
20110318278
2011-12-29

Foamable suspension gel

#509
20110312915
2011-12-22

Cosmetic compositions

#510
20110275672
2011-11-10

METHODS FOR TREATING CANCERS USING POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE

#511
20110275577
2011-11-10

METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS

#512
20110263693
2011-10-27

CELASTROL, GEDUNIN, AND DERIVATIVES THEREOF AS HSP90 INHIBITORS

#513
20110256130
2011-10-20

METHODS OF TREATING INFLAMMATORY DISORDERS

#514
20110251144
2011-10-13

MOLECULAR MODULATORS OF THE WNT/BETA-CATENIN PATHWAY

#515
20110212170
2011-09-01

Formulation for retinoid-containing soft gelatin capsules

#516
20110195941
2011-08-11

Methods of Use To Orally and Topically Treat Acne and Other Skin Conditions By Administering a 19-NOR Containing Vitamin D Analog With or Without a Retinoid

#517
20110190307
2011-08-04

Assay

#518
20110183943
2011-07-28

Concurrent therapy regime/regimen for the treatment of acne related diseases

#519
20110178051
2011-07-21

Topical skin care composition

#520
20110177025
2011-07-21

WOUND HEALING

#521
20110166113
2011-07-07

METHOD FOR TREATING THE HYPERPIGMENTATION OF PATHOLOGICAL SCARS

#522
20110166101
2011-07-07

MICROPARTICLES

#523
20110160306
2011-06-30

USE OF ALKANEDICARBOXYLIC ACIDS AND RETINOIDS FOR TREATMENT OF ROSACEA AND OTHER INFLAMMATORY SKIN DISEASES

#524
20110152372
2011-06-23

ANHYDROUS PETROLEUM JELLY/ELASTOMER-FREE DEPIGMENTING COMPOSITIONS COMPRISING A SOLUBILIZED PHENOLIC COMPOUND AND A RETINOID

#525
20110142922
2011-06-16

STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT

#526
20110142769
2011-06-16

Low toxicity topical active agent delivery system

#527
20110130461
2011-06-02

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

#528
20110118825
2011-05-19

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#529
20110081418
2011-04-07

Method of enhancing transdermal absorption using a composition comprising POE octyl dodecyl ether and squalane

#530
20110081410
2011-04-07

THERAPEUTIC AGENT FOR LOCAL INFLAMMATION

#531
20110081359
2011-04-07

Alpha 5 beta 1 and its ability to regulate the cell survival pathway

#532
20110076318
2011-03-31

RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED MATTERS

#533
20110071612
2011-03-24

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#534
20110070176
2011-03-24

Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid

#535
20110066251
2011-03-17

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#536
20110064708
2011-03-17

Methods and compositions for the dietary management of autoimmune disorders

#537
20110034554
2011-02-10

Compositions and methods for treating macular degeneration

#538
20110027367
2011-02-03

ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS

#539
20110027204
2011-02-03

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

#540
20110014135
2011-01-20

Vitamin formulation

#541
20110009360
2011-01-13

Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis

#542
20100322918
2010-12-23

Diffusion enhancing compounds and their use alone or with thrombolytics

#543
20100317109
2010-12-16

FACTOR

#544
20100311686
2010-12-09

Nutraceutical composition and methods for preventing or treating multiple sclerosis

#545
20100310680
2010-12-09

COMPOSITION AND METHOD FOR TREATING ACNE

#546
20100298259
2010-11-25

PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME

#547
20100298249
2010-11-25

PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME

#548
20100297249
2010-11-25

ENHANCEMENT OF THE EFFICACY OF THERAPEUTIC PROTEINS

#549
20100297113
2010-11-25

Quinone derivatives, pharmaceutical compositions, and uses thereof

#550
20100292314
2010-11-18

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#551
20100285008
2010-11-11

Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis

#552
20100278784
2010-11-04

METHODS AND COMPOSITIONS FOR TREATING SKIN CONDITIONS

#553
20100273882
2010-10-28

Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid

#554
20100255041
2010-10-07

Remedy for the treatment of cardio-vascular diseases or disorders

#555
20100240742
2010-09-23

Anti-angiogenic nanoparticle compositions

#556
20100221194
2010-09-02

Topical foam composition

#557
20100189695
2010-07-29

IRAK-1 AS REGULATOR OF DISEASES AND DISORDERS

#558
20100183741
2010-07-22

DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE

#559
20100178297
2010-07-15

Means and methods for the recruitment and identification of stem cells

#560
20100173957
2010-07-08

Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy

#561
20100166852
2010-07-01

Cream gels comprising at least one retinoid and benzoyl peroxide

#562
20100160439
2010-06-24

DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE

#563
20100152143
2010-06-17

Methods of treating skin disorders with caffeic acid analogs

#564
20100143445
2010-06-10

Dermatological/cosmetic skin depigmenting compositions

#565
20100136108
2010-06-03

Formulation for retinoid-containing soft gelatin capsules

#566
20100135977
2010-06-03

Methods for treating metabolic diseases

#567
20100125057
2010-05-20

TOPICAL SKIN CARE COMPOSITION

#568
20100113596
2010-05-06

Method for inhibiting liver fibrosis via retinoic acid derivative

#569
20100104644
2010-04-29

Compositions and Methods for Treating or Preventing Ophthalmic Disease

#570
20100092454
2010-04-15

NOVEL USE OF ANTIDEPRESSANT COMPOUNDS AND RELATED COMPOSITIONS

#571
20100087532
2010-04-08

MODULATION OF SIGNAL TRANSDUCTION

#572
20100056982
2010-03-04

Photodynamic therapy for the treatment of acne

#573
20100047357
2010-02-25

COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING A PEROXIDE AND RETINOID

#574
20100041753
2010-02-18

INHIBITION OF BIOFILM FORMATION

#575
20100029765
2010-02-04

TOPICAL AQUEOUS COMPOSITION COMPRISING TRETINOIN

#576
20100029601
2010-02-04

Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy

#577
20100028460
2010-02-04

IMPROVEMENTS IN RELATION TO CANCER THERAPY

#578
20100022997
2010-01-28

Method and process for producing youthful-appearing, small-pored, and smooth skin

#579
20100022642
2010-01-28

Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide

#580
20100004480
2010-01-07

METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS

#581
20100003307
2010-01-07

COMPOSITION AND USE OF RAR ANTAGONISTS FOR PROMOTING CHONDROGENESIS

#582
20090325914
2009-12-31

Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy

#583
20090325856
2009-12-31

Composition Designed For The Treatment Of Multiple Sclerosis

#584
20090318391
2009-12-24

Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent

#585
20090318384
2009-12-24

COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

#586
20090312296
2009-12-17

ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES

#587
20090281188
2009-11-12

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders

#588
20090281184
2009-11-12

PHARMACEUTICAL FOR PREVENTION AND TREATMENT OF OPHTHALMIC DISEASE INDUCED BY IN-CREASE IN VASOPERMEABILITY

#589
20090264527
2009-10-22

Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition

#590
20090258841
2009-10-15

COMPOSITIONS AND METHODS FOR SKIN CARE

#591
20090233894
2009-09-17

Compounds and methods for the treatment of cancer

#592
20090226426
2009-09-10

Method for treating inflammation

#593
20090220516
2009-09-03

Neuroprotection of retinal ganglion cells

#594
20090214504
2009-08-27

Methods and compositions for topical treatment of medical conditions including wounds and inflammation

#595
20090209601
2009-08-20

USE OF RXR AGONISTS FOR THE TREATMENT OF OSTEOARTHRITIS

#596
20090203784
2009-08-13

Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors

#597
20090197953
2009-08-06

Diagnostic assay for the specific treatment of acute myeloid leukemia

#598
20090196928
2009-08-06

Biocompatible hydrogel compositions

#599
20090192327
2009-07-30

METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS

#600
20090163550
2009-06-25

RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS